Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
US FDA Observation
52 week high
|
Strong Performer, Getting Expensive
1560.5000
29.90
(
1.95
%)
NSE
Jun 25, 2026
13:35 PM
New 52W High today
Volume:
1.3M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
11 Feb 2026
US FDA Observation
52 week high
1560.50
1.95%
Result Update:Aurobindo Pharma
Buy:
Aurobindo Pharma Ltd.
by
Axis Direct
Target: 1345 | Target met
Axis Direct
We maintain our BUY recommendation on the stock with a TP of Rs 1,345/share.
Aurobindo Pharma has gained
21.76%
in the last 3 Months
More from Aurobindo Pharma Ltd.
Recommended
Market trades higher, ED alleges FEMA violations by Rajesh Exports
Trendlyne Marketwatch |
25 Jun 2026, 01:35PM
PSU stake sales in Q1FY27 have already raised nearly as much as all of FY26. What's driving the …
The Baseline |
25 Jun 2026, 11:24AM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020